Clinical Trials Directory

Trials / Completed

CompletedNCT01426139

BIOFLOW-INDIA Safety and Clinical PerFormance of the Drug Eluting ORSIRO Stent in Single de Novo Coronary Artery Lesions

BIOTRONIK-Safety and Clinical PerFormance of the Drug Eluting ORSIRO Stent in the Treatment of Patients With Single de Novo Coronary Artery Lesions in an Indian Population

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
120 (actual)
Sponsor
Biotronik AG · Industry
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The objective of this clinical investigation is to assess the safety and clinical performance of the Orsiro Limus Eluting Stent System in Indian subjects with single de-novo coronary artery lesions.

Conditions

Interventions

TypeNameDescription
DEVICEPercutaneous Coronary Intervention Biotronik Orsiro DESStenting

Timeline

Start date
2011-08-01
Primary completion
2012-11-01
Completion
2013-02-01
First posted
2011-08-31
Last updated
2013-04-04

Locations

4 sites across 1 country: India

Source: ClinicalTrials.gov record NCT01426139. Inclusion in this directory is not an endorsement.

BIOFLOW-INDIA Safety and Clinical PerFormance of the Drug Eluting ORSIRO Stent in Single de Novo Coronary Artery Lesions (NCT01426139) · Clinical Trials Directory